Viewing Study NCT00501332


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-01-03 @ 6:29 AM
Study NCT ID: NCT00501332
Status: UNKNOWN
Last Update Posted: 2007-12-24
First Post: 2007-07-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Sponsor: Maxygen Holdings Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module